We have recently demonstrated involvement of KDM1A and H3K4 demethylation in the malignant progression of neuroblastoma, a challenging embryonal pediatric cancer sharing many morphological and molecular features with medulloblastoma [18]. Here, KDM1A is linked to cancer.